Age-Stratified Clinical Outcome in Patients with Known Heart Failure Who Receive Pacemaker, Resynchronization Therapy, or Defibrillator Implants
Cardiology · 2024
DOI: 10.1159/000538529 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cardiology, 2024. Verfasst von Cecilia Rorsman und 4 weiteren Autor:innen. Beteiligte Einrichtung: Cardiology, Department of Clinical Sciences, Lund University, Lund, Sweden. Hauptthemen laut MEDLINE: Heart Failure, Defibrillators, Implantable, Cardiac Resynchronization Therapy, Pacemaker, Artificial. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Herzinsuffizienz
Abstract (Originalsprache)
Introduction
Patients with heart failure (HF) and bradycardia may be eligible for different types of cardiac implantable electronic devices (CIED), depending on the presence of atrioventricular conduction disease, age, and comorbidities. We aimed to assess the prognosis for these patients, after CIED implantation, stratified for the type of CIED device.
Methods
All patients with preexisting HF diagnosis who received a CIED with a right ventricular lead during the period 2005–2018 in Sweden were identified via the pacemaker registry. Data were crossmatched with the population registry and national disease registries. The outcome was 5-year risk of HF hospitalization and mortality.
Results
A total of 37,745 patients were included in the study. Comparing demographics for implantable cardioverter defibrillator versus pacemaker implants, median age was 66 years versus 83 years, 20% versus 41% were female, 64% versus 50% had ischemic heart disease, and 35% versus 67% had atrial fibrillation (all p < 0.001). Five-year mortality was highest in single-chamber pacemaker recipients (61% compared to average 40%, p < 0.001), but the proportion of cardiovascular mortality was highest for cardiac resynchronization therapy (CRT) recipients (68% vs. 63% p < 0.001). Adjusted mortality was higher for pacemaker patients in all age decile groups (ranging from <60 to >90 years old, all p < 0.001), HF hospitalization occurred in 28% (dual-chamber pacemaker) to 39% (CRT-P) of patients, and cause of death was HF in 15% (dual-chamber pacemaker) to 25% (CRT-D), all p < 0.001.
Conclusion
In this large real-world cohort of CIED-treated patients with prior HF, demography and mortality data indicate that clinicians chose devices according to the overall status of the patient. HF-related events occurred in all groups but were more common in CRT-treated patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Cardiology, Department of Clinical Sciences, Lund University, Lund, Sweden.
- Internal Medicine Department, Varberg Hospital, Varberg, Sweden.
- Arrhythmia Section, Heart and Lung Division, Skane University Hospital, Lund, Sweden.
Zitieren
APA
Rorsman, C., Farouq, M., Marinko, S., Platonov, P. G., & Borgquist, R. (2024). Age-Stratified Clinical Outcome in Patients with Known Heart Failure Who Receive Pacemaker, Resynchronization Therapy, or Defibrillator Implants. Cardiology. https://doi.org/10.1159/000538529
Vancouver
Rorsman C, Farouq M, Marinko S, Platonov PG, Borgquist R. Age-Stratified Clinical Outcome in Patients with Known Heart Failure Who Receive Pacemaker, Resynchronization Therapy, or Defibrillator Implants. Cardiology. 2024. doi:10.1159/000538529
BibTeX
@article{Rorsman2024,
author = {Rorsman, Cecilia and Farouq, Maiwand and Marinko, Sofia and Platonov, Pyotr G and Borgquist, Rasmus},
title = {Age-Stratified Clinical Outcome in Patients with Known Heart Failure Who Receive Pacemaker, Resynchronization Therapy, or Defibrillator Implants},
journal = {Cardiology},
year = {2024},
doi = {10.1159/000538529}
}
EUVIMED